The FTC vs POM Wonderful: The case continues ...
While POM Wonderful did not emerge from a May ruling on a false advertising case from administrative law judge Michael Chappell ruling smelling entirely of roses, it did challenge the accepted wisdom that firms can only make claims about food or supplements if they are backed at least two human clinical trials: Attorney: POM ruling is a 'stunning rejection' of FTC's stance on 'gold standard' clinical trials to support product claims
Both sides claim victory as judge rules in FTC v POM false advertising case
The next installment of the FTC vs POM is on January 18, so stay tuned: Will POM Wonderful case finally clear up confusion over what evidence is needed to support ad claims?